文献速递乳房整形与再造显微修复重建

显微乳房再造术后静脉血栓栓塞:12,778例纵向分析

Venous Thromboembolism following Microsurgical Breast Reconstruction: A Longitudinal Analysis of 12,778 Patients.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

基于Truven MarketScan数据库的回顾性队列研究,纳入2007至2015年接受显微乳房再造的12,778例女性,分析术后90天内静脉血栓栓塞(VTE)的可改变危险因素及纵向变化。167例(1.3%)发生VTE,67.1%发生于出院后,2007至2015年发生率无显著变化。Elixhauser评分、VTE病史和住院时长是显著预测因素。

要点

  • 显微乳房再造术后90天内VTE发生率为1.3%,多数(67.1%)发生于出院后。
  • VTE病史、Elixhauser评分和住院时长是VTE的显著预测因素。
  • 出院后VTE患者平均Elixhauser评分低于住院期间VTE患者。

核心结论

  • 显微乳房再造术后VTE发生率在研究期间保持稳定,仍为未充分解决的问题。
  • 识别可改变危险因素如住院时长,为干预提供潜在途径。
  • 多数VTE发生于出院后,需未来研究探讨该时期干预的作用。

研究设计与样本

  • 使用Truven MarketScan数据库的回顾性队列研究。
  • 纳入2007至2015年接受显微乳房再造且术后90天内发生VTE的女性。
  • 预测变量包括年龄、再造时机、BMI、放疗史、VTE病史、Elixhauser合并症指数和住院时长。
  • 采用单变量分析、逻辑回归和零膨胀泊松回归评估预测因素及VTE变化。

主要发现

  • 共识别12,778例女性,其中167例(1.3%)发生VTE。
  • 67.1%的VTE发生于出院后,2007至2015年无显著变化。
  • VTE显著预测因素包括Elixhauser评分(p < 0.01)、VTE病史(p < 0.03)和住院时长(p < 0.001)。
  • 出院后VTE患者平均Elixhauser评分低于住院期间VTE患者(p < 0.001)。

临床怎么用

  • 对显微乳房再造患者应关注VTE病史、合并症评分和住院时长等危险因素。
  • 出院后仍需警惕VTE发生,可能需考虑延长预防或监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism is a dreaded complication following microsurgical breast reconstruction. Although the high-risk nature of the procedure is well known, a thorough analysis of modifiable risk factors has not been performed. The purpose of this study was to analyze the association of such factors with the postoperative occurrence of venous thromboembolism longitudinally. METHODS: Using the Truven MarketScan Database, a retrospective cohort study of women who underwent microsurgical breast reconstruction from 2007 to 2015 and who developed postoperative venous thromboembolism within 90 days of reconstruction was performed. Predictor variables included age, timing of reconstruction, body mass index, history of radiation therapy, history of venous thromboembolism, Elixhauser Comorbidity Index, and length of stay. Univariate analyses were performed, in addition to logistic and zero-inflated Poisson regressions, to evaluate predictors of venous thromboembolism and changes in venous thromboembolism over the study period, respectively. RESULTS: Twelve thousand seven hundred seventy-eight women were identified, of which 167 (1.3 percent) developed venous thromboembolism. The majority of venous thromboembolisms (67.1 percent) occurred following discharge, with no significant change from 2007 to 2015. Significant predictors of venous thromboembolism included Elixhauser score (p < 0.01), history of venous thromboembolism (p < 0.03), and length of stay (p < 0.001). Compared to patients who developed a venous thromboembolism during the inpatient stay, patients who developed a postdischarge venous thromboembolism had a lower mean Elixhauser score (p < 0.001). CONCLUSIONS: Postoperative venous thromboembolism continues to be an inadequately addressed problem, as evidenced by a stable incidence over the study period. Identification of modifiable risk factors, such as length of stay, provides potential avenues for intervention. As the majority of venous thromboembolisms occur following discharge, future studies are warranted to investigate the role for an intervention in this period. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Rochlin DH, Sheckter CC, Pannucci C, et al. Venous Thromboembolism following Microsurgical Breast Reconstruction: A Longitudinal Analysis of 12,778 Patients. Plast Reconstr Surg. 2020. PMID: 32453267. doi:10.1097/PRS.0000000000007051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。